Rio2 Limited (TSX:RIO) Completes Brokered Private Placement

VANCOUVER, British Columbia — December 17, 2025 — Leads & Copy — Rio2 Limited (TSX: RIO; OTCQX: RIOFF; BVL: RIO) has announced the closing of its previously announced brokered private placement. The company sold 6,306,300 common shares to investors in Peru and Chile at C$2.22 per share, resulting in gross proceeds of C$14 million.

KALLPA Securities Sociedad Agente de Bolsa S.A. served as the agent for the Private Placement.

The net proceeds from the Private Placement will be used for working capital and general corporate purposes. The Toronto Stock Exchange’s final acceptance is contingent upon completing standard post-closing filings.

The securities have not been registered under the U.S. Securities Act of 1933 and may not be offered or sold in the United States or to “U.S. Persons” absent registration or an applicable exemption.

Rio2 is focused on taking its Fenix Gold Project in Chile to production. The company is committed to environmental standards and sustainable development.

Alex Black, Executive Chairman of the Board, and Kathryn Johnson, Executive Vice President, CFO & Corporate Secretary can be contacted for further information.

Alex Black
Executive Chairman of the Board
Email: alex.black@rio2.com
Tel: +51 99279 4655

Kathryn Johnson
Executive Vice President, CFO & Corporate Secretary
Email: kathryn.johnson@rio2.com
Tel: +1 604 762 4720

Source: Rio2 Limited

×

Welcome!

Biotech Reporter is the source most up-to-date real-time, direct-from-source News Tips and Story Leads.

By Subscribing you will receive Daily Biotech Update each day at 9:30 am ET (Market Open) in your inbox and you can unsubscribe any time.